BACKGROUND: Tenascin-C (TNC) is an extracellular matrix glycoprotein, usually derived from myofibroblasts in the cancer microenvironment. Recently, however, the significance of tumor-derived TNC in initiation of cancer metastasis was disclosed. We investigated the clinical significance of cancer-derived TNC in colorectal cancer (CRC) cases. MATERIALS AND METHODS: TNC expression in 170 cases of CRC was analyzed by quantitative real-time polymerase chain reaction (PCR). In addition, gene expression arrays using purely-separated cancer tissues of another 86 cases was performed and the functional implications of cancer-specific TNC were investigated. RESULTS: The expression of TNC mRNA was significantly higher in CRC tissues than in the corresponding normal tissues. Cancer cell-specific TNC expression was a significant prognostic factor in CRC cases. Moreover, cancer cell-derived TNC was associated with the epithelial-mesenchymal transition (EMT) signature. CONCLUSION: Cancer cell-derived TNC promotes cancer invasiveness via EMT regulation, and not cancer tissue TNC but cancer cell-specific TNC is a novel indicator of poor prognosis.
BACKGROUND:Tenascin-C (TNC) is an extracellular matrix glycoprotein, usually derived from myofibroblasts in the cancer microenvironment. Recently, however, the significance of tumor-derived TNC in initiation of cancer metastasis was disclosed. We investigated the clinical significance of cancer-derived TNC in colorectal cancer (CRC) cases. MATERIALS AND METHODS:TNC expression in 170 cases of CRC was analyzed by quantitative real-time polymerase chain reaction (PCR). In addition, gene expression arrays using purely-separated cancer tissues of another 86 cases was performed and the functional implications of cancer-specific TNC were investigated. RESULTS: The expression of TNC mRNA was significantly higher in CRC tissues than in the corresponding normal tissues. Cancer cell-specific TNC expression was a significant prognostic factor in CRC cases. Moreover, cancer cell-derived TNC was associated with the epithelial-mesenchymal transition (EMT) signature. CONCLUSION:Cancer cell-derived TNC promotes cancer invasiveness via EMT regulation, and not cancer tissue TNC but cancer cell-specific TNC is a novel indicator of poor prognosis.
Authors: Sunghee Woo; Seong Won Cha; Stefano Bonissone; Seungjin Na; David L Tabb; Pavel A Pevzner; Vineet Bafna Journal: J Proteome Res Date: 2015-07-21 Impact factor: 4.466
Authors: Camila Espejo; Richard Wilson; Eduard Willms; Manuel Ruiz-Aravena; Ruth J Pye; Menna E Jones; Andrew F Hill; Gregory M Woods; A Bruce Lyons Journal: Cell Mol Life Sci Date: 2021-10-16 Impact factor: 9.261
Authors: Henna M Karvonen; Siri T Lehtonen; Terttu Harju; Raija T Sormunen; Elisa Lappi-Blanco; Johanna M Mäkinen; Kirsi Laitakari; Shirley Johnson; Riitta L Kaarteenaho Journal: Respir Res Date: 2013-08-11
Authors: Joni Leppänen; Sara Bogdanoff; Petri P Lehenkari; Juha Saarnio; Joonas H Kauppila; Tuomo J Karttunen; Heikki Huhta; Olli Helminen Journal: Oncotarget Date: 2017-07-12